Schering-Plough Products, LLC

FDA Regulatory Profile

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-139-2013Class IITemodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, December 12, 2012